United States
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 42.37 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
2 |
USD 41.22 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
3 |
USD 21.97 B
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
4 |
USD 20.18 B
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
5 |
USD 19.56 B
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
6 |
USD 15.91 B
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
7 |
USD 8.27 B
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
8 |
USD 7.87 B
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
9 |
USD 7.60 B
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
10 |
USD 6.91 B
|
Sept. 30, 2024 | USD 179.15 | 1.50% |
|
United States |
|
11 |
USD 5.87 B
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
12 |
USD 4.81 B
|
Sept. 30, 2024 | USD 228.83 | -0.62% |
|
United States |
|
13 |
USD 4.03 B
|
Sept. 28, 2024 | USD 70.20 | -0.13% |
|
United States |
|
14 |
USD 3.96 B
|
Sept. 30, 2024 | USD 210.46 | -1.51% |
|
United States |
|
15 |
USD 3.95 B
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
16 |
USD 3.76 B
|
Sept. 30, 2024 | USD 1.27 K | 0.33% |
|
United States |
|
17 |
USD 3.54 B
|
Sept. 30, 2024 | USD 111.11 | 1.26% |
|
United States |
|
18 |
USD 3.26 B
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
19 |
USD 3.24 B
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
20 |
USD 3.03 B
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
21 |
USD 2.82 B
|
Sept. 29, 2024 | USD 41.10 | -7.87% |
|
United States |
|
22 |
USD 2.48 B
|
Sept. 30, 2024 | USD 88.18 | 1.15% |
|
United States |
|
23 |
USD 2.34 B
|
Sept. 30, 2024 | USD 161.08 | 1.85% |
|
United States |
|
24 |
USD 2.04 B
|
Sept. 28, 2024 | USD 166.09 | 0.31% |
|
United States |
|
25 |
USD 2.00 B
|
Sept. 27, 2024 | USD 44.75 | -1.32% |
|
United States |
|
26 |
USD 1.81 B
|
Sept. 30, 2024 | USD 267.04 | -0.35% |
|
United States |
|
27 |
USD 1.77 B
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
28 |
USD 1.70 B
|
Sept. 27, 2024 | USD 138.83 | 2.72% |
|
United States |
|
29 |
USD 1.56 B
|
Sept. 30, 2024 | USD 21.93 | -1.62% |
|
United States |
|
30 |
USD 1.50 B
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
31 |
USD 1.36 B
|
Sept. 28, 2024 | USD 79.96 | 0.69% |
|
United States |
|
32 |
USD 1.32 B
|
Sept. 30, 2024 | USD 99.89 | 4.44% |
|
United States |
|
33 |
USD 1.29 B
|
Sept. 30, 2024 | USD 67.79 | -2.46% |
|
United States |
|
34 |
USD 1.16 B
|
Sept. 30, 2024 | USD 252.89 | 2.41% |
|
United States |
|
35 |
USD 1.12 B
|
Sept. 30, 2024 | USD 20.10 | 0.95% |
|
United States |
|
36 |
USD 973.67 M
|
Sept. 30, 2024 | USD 35.79 | -1.16% |
|
United States |
|
37 |
USD 922.75 M
|
Sept. 27, 2024 | USD 148.22 | 1.40% |
|
United States |
|
38 |
USD 836.90 M
|
Sept. 30, 2024 | USD 16.29 | 2.65% |
|
United States |
|
39 |
USD 811.00 M
|
Sept. 27, 2024 | USD 13.52 | 1.05% |
|
United States |
|
40 |
USD 784.25 M
|
Sept. 30, 2024 | USD 17.51 | 0.81% |
|
United States |
|
41 |
USD 681.50 M
|
Sept. 30, 2024 | USD 15.83 | 0.19% |
|
United States |
|
42 |
USD 629.74 M
|
Sept. 30, 2024 | USD 15.44 | -1.72% |
|
United States |
|
43 |
USD 574.50 M
|
Sept. 30, 2024 | USD 79.30 | -0.05% |
|
United States |
|
44 |
USD 560.02 M
|
Sept. 30, 2024 | USD 99.01 | 4.67% |
|
United States |
|
45 |
USD 555.06 M
|
Sept. 28, 2024 | USD 8.87 | -3.17% |
|
United States |
|
46 |
USD 516.85 M
|
Sept. 30, 2024 | USD 50.77 | 2.13% |
|
United States |
|
47 |
USD 490.74 M
|
Sept. 30, 2024 | USD 4.22 | NA |
|
United States |
|
48 |
USD 451.29 M
|
Sept. 30, 2024 | USD 13.47 | -1.25% |
|
United States |
|
49 |
USD 447.57 M
|
Sept. 30, 2024 | USD 34.69 | 0.87% |
|
United States |
|
50 |
USD 419.15 M
|
Sept. 30, 2024 | USD 3.70 | -8.19% |
|
United States |
The Medical Instruments company in United States with the highest Revenue is Thermo Fisher Scientific Inc. (NYSE: TMO) at USD 42.37 B.
The Medical Instruments company in United States with the lowest Revenue is Autonomix Medical, Inc. Common Stock (NasdaqCM: AMIX) at USD 0.00.
The top 10 Medical Instruments companies in United States by Revenue are Thermo Fisher Scientific Inc., Abbott Laboratories, Stryker Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Boston Scientific Corporation, Solventum Corporation, Intuitive Surgical, Inc., Zimmer Biomet Holdings, Inc. and AMETEK, Inc..
The bottom 10 Medical Instruments companies in United States by Revenue are Autonomix Medical, Inc. Common Stock, HeartBeam, Inc., Sharps Technology, Inc., Heart Test Laboratories, Inc., BioSig Technologies, Inc., SeaStar Medical Holding Corporation, Nexalin Technology, Inc., Envoy Medical, Inc., ENDRA Life Sciences Inc. and Vivani Medical, Inc..